论文部分内容阅读
冠状动脉介入治疗近十余年来取得了迅速发展 ,其对冠心病的治疗价值已得到众多随机临床试验的证实。但经皮冠状动脉介入治疗 (PCI)术后最突出的问题是术后再狭窄。临床实验证实射心通胶囊具有抑制血小板聚集、抗血栓形成、降低血浆内皮素及血脂等作用[1] 。本研究主要探讨了射
The interventional treatment of coronary artery has achieved rapid development in the past more than ten years. Its therapeutic value for coronary heart disease has been confirmed by numerous randomized clinical trials. However, the most prominent problem after percutaneous coronary intervention (PCI) is postoperative restenosis. Clinical trials have confirmed that Shexintong capsule has the effects of inhibiting platelet aggregation, antithrombosis, reducing plasma endothelin, and blood lipids [1]. This study mainly discusses shots